They have both been shown to down-regulate inflammation through the modulation of NF-κB signaling, reduce emphysema through inhibition of matrix metalloproteinase expression, and also regulate the expression of several anti-oxidant genes12, 14, 38, 39. Here, NFKB1 is linked to pulmonary emphysema.